Last reviewed · How we verify
Tacrolimus 0.1% manufactured by Taro
Tacrolimus 0.1% manufactured by Taro is a Small molecule drug developed by Sun Pharmaceutical Industries, Inc.. It is currently in Phase 1 development.
At a glance
| Generic name | Tacrolimus 0.1% manufactured by Taro |
|---|---|
| Sponsor | Sun Pharmaceutical Industries, Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Tacrolimus 0.1% manufactured by Taro CI brief — competitive landscape report
- Tacrolimus 0.1% manufactured by Taro updates RSS · CI watch RSS
- Sun Pharmaceutical Industries, Inc. portfolio CI
Frequently asked questions about Tacrolimus 0.1% manufactured by Taro
What is Tacrolimus 0.1% manufactured by Taro?
Tacrolimus 0.1% manufactured by Taro is a Small molecule drug developed by Sun Pharmaceutical Industries, Inc..
Who makes Tacrolimus 0.1% manufactured by Taro?
Tacrolimus 0.1% manufactured by Taro is developed by Sun Pharmaceutical Industries, Inc. (see full Sun Pharmaceutical Industries, Inc. pipeline at /company/sun-pharmaceutical-industries-inc).
What development phase is Tacrolimus 0.1% manufactured by Taro in?
Tacrolimus 0.1% manufactured by Taro is in Phase 1.